Janney Montgomery Scott LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 157 filers reported holding CARA THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.

Quarter-by-quarter ownership
Janney Montgomery Scott LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q3 2020$149,000
-33.2%
11,714
-10.3%
0.00%0.0%
Q2 2020$223,000
+27.4%
13,064
-1.1%
0.00%0.0%
Q1 2020$175,000
-41.5%
13,214
-28.8%
0.00%
-50.0%
Q4 2019$299,000
-21.3%
18,549
-10.9%
0.00%
-33.3%
Q3 2019$380,000
-16.8%
20,812
-2.2%
0.00%
-25.0%
Q2 2019$457,000
-5.8%
21,273
-13.9%
0.00%0.0%
Q1 2019$485,000
+29.0%
24,696
-14.6%
0.00%0.0%
Q4 2018$376,000
-48.8%
28,928
-5.6%
0.00%
-33.3%
Q3 2018$734,000
+28.3%
30,628
+2.5%
0.01%0.0%
Q2 2018$572,000
+34.3%
29,875
-13.1%
0.01%
+50.0%
Q1 2018$426,000
-39.2%
34,375
-40.0%
0.00%
-42.9%
Q4 2017$701,000
+140.1%
57,279
+168.1%
0.01%
+133.3%
Q3 2017$292,000
+11.0%
21,365
+25.0%
0.00%0.0%
Q2 2017$263,000
-45.8%
17,090
-35.1%
0.00%
-50.0%
Q1 2017$485,000
-24.6%
26,350
-61.9%
0.01%
-40.0%
Q4 2016$643,000
+44.5%
69,189
+29.7%
0.01%
+25.0%
Q3 2016$445,000
-6.5%
53,339
-46.1%
0.01%
-20.0%
Q2 2016$476,000
+55.6%
98,956
+101.4%
0.01%
+25.0%
Q1 2016$306,000
-59.4%
49,128
+10.1%
0.01%
-57.9%
Q4 2015$753,000
+109.2%
44,639
+77.1%
0.02%
+90.0%
Q3 2015$360,000
-99.8%
25,200
+54.1%
0.01%
+150.0%
Q2 2015$198,653,000
+156319.7%
16,350
+29.8%
0.00%
+100.0%
Q1 2015$127,000
-99.9%
12,600
-8.0%
0.00%
-33.3%
Q4 2014$136,589,00013,7000.00%
Other shareholders
CARA THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Bain Capital Life Sciences Investors, LLC 2,204,449$10,8241.35%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,233,000$6,054,0301.14%
Chescapmanager LLC 1,160,392$5,6980.90%
DISCIPLINED GROWTH INVESTORS INC /MN 1,732,375$8,505,9610.22%
XTX Topco Ltd 107,610$528,3650.11%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$415,0420.08%
PINNACLE ASSOCIATES LTD 679,413$3,335,9180.07%
PDT Partners, LLC 102,010$500,8690.07%
FARALLON CAPITAL MANAGEMENT LLC 1,995,370$9,797,2670.05%
AXQ CAPITAL, LP 27,760$136,3020.05%
View complete list of CARA THERAPEUTICS INC shareholders